Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre–post trial design

Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre–post trial design

Introduction While living donor (LD) kidney transplantation is the optimal treatment for patients with kidney failure, LDs assume a higher risk of future kidney failure themselves. LDs of African ancestry have an even greater risk of kidney failure post-donation than White LDs. Because evidence sugg...

Full description

Bibliographic Details
Main Authors: Matthew Cooper, Justin D Smith, Clyde W Yancy, Elisa J Gordon, Akansha Agrawal, Catherine Wicklund, Debra Duquette, John Friedewald, Luke V Rasmussen, Jessica Gacki-Smith, S. Darius Tandon, Lutfiyya N Muhammad, Siyuan Dong, Alexander Gilbert, Aneesha Shetty
Format: Article
Language:English
Published: BMJ Publishing Group 2023-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/5/e067657.full

Internet

https://bmjopen.bmj.com/content/13/5/e067657.full

Similar Items